Amarin Corporation/$AMRN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Amarin Corporation
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.
Ticker
$AMRN
Sector
Primary listing
Employees
80
Headquarters
Dublin, Ireland
Website
AMRN Metrics
BasicAdvanced
$332M
-
-$1.87
0.89
-
Price and volume
Market cap
$332M
Beta
0.89
52-week high
$20.90
52-week low
$8.32
Average daily volume
85K
Financial strength
Current ratio
3.342
Quick ratio
2.208
Long term debt to equity
1.324
Total debt to equity
1.324
Interest coverage (TTM)
-1,991.57%
Profitability
EBITDA (TTM)
-10.913
Gross margin (TTM)
56.57%
Net profit margin (TTM)
-18.16%
Operating margin (TTM)
-6.53%
Effective tax rate (TTM)
-7.63%
Revenue per employee (TTM)
$2,670,000
Management effectiveness
Return on assets (TTM)
-1.28%
Return on equity (TTM)
-8.21%
Valuation
Price to revenue (TTM)
1.551
Price to book
0.72
Price to tangible book (TTM)
0.75
Price to free cash flow (TTM)
49.236
Free cash flow yield (TTM)
2.03%
Free cash flow per share (TTM)
0.324
Growth
Revenue change (TTM)
-6.55%
Earnings per share change (TTM)
-53.25%
3-year revenue growth (CAGR)
-16.67%
10-year revenue growth (CAGR)
10.08%
3-year earnings per share growth (CAGR)
-29.23%
10-year earnings per share growth (CAGR)
-19.62%
AMRN News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Amarin Corporation stock?
Amarin Corporation (AMRN) has a market cap of $332M as of March 11, 2026.
What is the P/E ratio for Amarin Corporation stock?
The price to earnings (P/E) ratio for Amarin Corporation (AMRN) stock is 0 as of March 11, 2026.
Does Amarin Corporation stock pay dividends?
No, Amarin Corporation (AMRN) stock does not pay dividends to its shareholders as of March 11, 2026.
When is the next Amarin Corporation dividend payment date?
Amarin Corporation (AMRN) stock does not pay dividends to its shareholders.
What is the beta indicator for Amarin Corporation?
Amarin Corporation (AMRN) has a beta rating of 0.89. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.